Home 
Research Health FDA Alerts Merck Recalls 3 Lots Of Invanz
Research Health FDA Alerts Merck Recalls 3 Lots Of Invanz | Merck Recalls 3 Lots Of Invanz |
|
|
|
| Written by Ramaz Mitaishvili | |
| Sunday, 19 August 2007 | |
 FDA - MedWatch - Merck Recalls 3 Lots Of Invanz (ertapenem sodium) Injection Because The Product May Contain Broken Glass Pieces In The Reconstituted Solution For Injection
MedWatch - The FDA Safety Information and Adverse Event Reporting ProgramMerck and FDA informed healthcare professionals that 3 lots of Invanz (0803930, 0803940, and 0803950), a product indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated microorganisms, were recalled. The product was recalled because of two incidents of finding broken glass pieces in the reconstituted solution for injection. Healthcare professionals are advised to immediately stop dispensing all products from the three lots specified above. No other lots are affected by this recall. |
| < Prev |
|---|
Foundation Georgia
www.foundationgeorgia.com
Copyright © 2005 - 2009 Abkhazia Institute for Social and Economic Research.
Designed by irakli.org
Joomla! is Free Software released under the GNU/GPL License.
Joomla! is Free Software released under the GNU/GPL License.
